KALV icon

KalVista Pharmaceuticals
KALV

Overview Fund Activity

75 hedge funds and large institutions have $328M invested in KalVista Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 20 increasing their positions, 18 reducing their positions, and 17 closing their positions.

Holders
75
Holders Change
+7
Holders Change %
+10.29%
% of All Funds
1.63%
Holding in Top 10
4
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-42.86%
% of All Funds
0.09%
New
24
Increased
20
Reduced
18
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BlackRock
1
BlackRock
New York
$16.3M
2
EAM
2
Eventide Asset Management
Massachusetts
$33.2M
3
DM
3
Deerfield Management
New York
$27M
4
PAMU
4
Pictet Asset Management (UK)
United Kingdom
$10.1M
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$21.6M

Top Sellers

1
RCM
1
RA Capital Management
Massachusetts
$0
2
VMI
2
VHCP Management III
New York
$14.1M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$0
4
VMI
4
VHCP Management II
New York
$8.35M
5
O
5
OrbiMed
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
SHI
1
SV Health Investors
Massachusetts
$38.1M 1,719,576 -111,972 -6%
EAM
2
Eventide Asset Management
Massachusetts
$33.2M 1,500,000 +600,000 +67%
PC
3
Polar Capital
United Kingdom
$30.7M 1,387,500 +238,300 +21%
VC
4
Vivo Capital
California
$30.1M 1,359,149 – –
DM
5
Deerfield Management
New York
$27M 1,217,668 +567,668 +87%
Fidelity Investments
6
Fidelity Investments
Massachusetts
$21.6M 976,480 +241,466 +33%
BlackRock
7
BlackRock
New York
$16.3M 736,782 +666,525 +949%
Adage Capital Partners
8
Adage Capital Partners
Massachusetts
$15.5M 700,000 +35,000 +5%
VMI
9
VHCP Management III
New York
$14.1M 637,884 -332,746 -34%
Vanguard Group
10
Vanguard Group
Pennsylvania
$11.7M 527,829 +170,439 +48%
PAMU
11
Pictet Asset Management (UK)
United Kingdom
$10.1M 454,486 +454,486 New
IVM
12
InterWest Venture Management
California
$8.61M 388,766 – –
VMI
13
VHCP Management II
New York
$8.35M 376,889 -196,593 -34%
GTC
14
Ghost Tree Capital
New York
$6.65M 300,000 -100,000 -25%
Invesco
15
Invesco
Georgia
$5.73M 258,673 -55,118 -18%
ACP
16
Acuta Capital Partners
California
$4.72M 213,000 +7,500 +4%
State Street
17
State Street
Massachusetts
$4.45M 200,826 +192,251 +2,242%
BC
18
Boxer Capital
California
$4.43M 200,000 – –
IBT
19
International Biotechnology Trust
United Kingdom
$4.17M 187,599 -25,462 -12%
Point72 Asset Management
20
Point72 Asset Management
Connecticut
$3.61M 162,900 +162,900 New
Geode Capital Management
21
Geode Capital Management
Massachusetts
$3.14M 141,869 +58,774 +71%
SB
22
Samsara BioCapital
California
$2.63M 118,500 – –
Dimensional Fund Advisors
23
Dimensional Fund Advisors
Texas
$2.47M 111,630 +39,083 +54%
SSA
24
Schonfeld Strategic Advisors
New York
$2.36M 106,400 +95,400 +867%
Northern Trust
25
Northern Trust
Illinois
$1.64M 73,830 +32,930 +81%
1
2 3 4